ArticleEJIFCC2026
Comprehensive Analysis and Correlation of Serum 25-Hydroxyvitamin D3 Levels with Glycemia and Cardiometabolic Risk Factors: A Tertiary Care Hospital-Based Study.
Article in EJIFCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Role of Vitamin D is not limited to skeletal health but it acts as a potential modulator of metabolic homeostasis. Studies have shown its influence on insulin secretion and cardiometabolic risk factors. This study was conducted to evaluate correlation of serum 25-hydroxy vitamin D3 (25OH VitD3) levels with glycemic status and lipid profile parameters in a tertiary care hospital setting. Methods: A cross-sectional observational study was conducted taking 173 adults (>18 years) attending outpatient department of a tertiary care hospital between April and December 2025. Participants were categorized based on HbA1c levels according to American Diabetes Association criteria into non-diabetic, pre-diabetic, and diabetic. 25OH VitD3, total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) were estimated from fasting serum sample. Statistical analyses were performed and statistical significance was set at p<0.05. Results: Vitamin D deficiency and insufficiency were observed in more than 65% of participants (mean 25OH VitD3: 27.8±16.16 ng/mL). Patients with diabetes mellitus showed significantly higher TG, VLDL, TG/HDL and TC/HDL ratios and lower HDL levels (p<0.05). 25OH VitD3 showed a weak statistically significant negative correlation with HbA1c (ρ = -0.186, p=0.014) but no significant correlation with lipid parameters. Regression models revealed moderate explanatory power (R Conclusion: A high prevalence of vitamin D deficiency was detected. Vitamin D demonstrated a weak correlation with glycemia and no correlation with lipid parameters. Vitamin D may function as a metabolic modulator rather than a primary determinant of dysglycemia and dyslipidemia.
Indexed as
Identifiers
42729968PMC13563525What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.